http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9628025-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d64dbbe008c5f285641d36f43ad87408 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_535e68b2a2738006f66bf14379171d44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ed477a31fb39da5f2937e7bbe04a5150 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-115 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-0088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-16 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-115 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L2-00 |
| filingDate | 1996-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f46319877fe5171f17131e88abbf9c6e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80e3c647275b343be433b26473d7d804 |
| publicationDate | 1996-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-9628025-A1 |
| titleOfInvention | Inactivation of pathogens in blood and/or blood products using formaldehyde |
| abstract | A method of inactivating pathogens present in blood products containing plasma protein and/or in whole blood intended for blood transfusion. In accordance with the teachings of the present invention, the method comprises treating the whole blood or blood product with formaldehyde in a concentration of about 0.05 %-0.25 %, preferably about 0.1 %-0.2 % and more preferably about 0.15 %, by weight of the whole blood or blood product so as to inactivate any pathogens present therewithin. The present invention is also directed to a method of treating a patient in need of whole blood or a blood constituent which comprises treating a sample of whole blood or a blood product comprising the blood constituent and plasma protein with formaldehyde in the manner described above and then administering the formaldehyde-treated blood or blood constituent to the patient in need thereof. Preferably, after the treating step and prior to the administering step, residual formaldehyde is removed from the blood sample. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1163903-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1163903-A2 |
| priorityDate | 1995-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 54.